Constellation Brands, Inc. (STZ) Down 5.3% — Pull the Trigger on a Sell?

  • STZ fell 5.29% to $131.81 from $139.18 the previous trading day
  • Weiss Ratings assigns C- (Hold)
  • Market cap is $23.77B with a dividend yield of 2.95%

Constellation Brands, Inc. (STZ) had a rough Monday on the NYSE, sliding 5.29% and shedding $7.37 to close at $131.81. The move deepens an already painful drawdown for shareholders — the stock now sits approximately 22.9% below its 52-week high of $171.00, a level last reached on August 15, 2025, and the distance from that peak continues to widen with each selling session.

Volume came in at roughly 400,000 shares, a fraction of the 90-day average of approximately 2.15 million. The dramatically below-average turnover is notable: a drop of this magnitude on thin volume suggests the selling was not broad-based capitulation, but rather a market with few buyers willing to step in and absorb even modest pressure.


Why Constellation Brands, Inc. Price is Moving Lower

The primary catalysts behind today's decline are the weight of accumulating demand data pointing to structural weakness in the U.S. beer market and STZ's inability to outrun it. NielsenIQ figures for the four weeks ended August 1 showed total U.S. beer dollar sales down 3.9% year over year and case volume down 5.2%, with weaker consumer demand accounting for 71% of that decline. Critically, Constellation's own portfolio was not insulated: the company's sales fell 1.8% and case volume dropped by 623,500 units during the period. The flagship Modelo brand — long the engine of STZ's outperformance — saw dollar sales decline 2.8%, while Corona sales fell a steeper 5.3%. For a company whose investment thesis has rested heavily on the premium-pricing power and secular share gains of its Mexican-import beer portfolio, those numbers represent a meaningful challenge to the narrative.

The broader fundamental backdrop compounds the concern. Constellation's fiscal Q1 2027 report, released on June 30, delivered a mixed picture: comparable EPS of $3.43 beat the roughly $3.25 consensus estimate, and revenue of $2.43 billion edged past the $2.41 billion expectation — but revenue still declined 3.3% year over year. Operating margin improved to 34.7% from 28.4%, which offered some reassurance, yet management's full-year comparable EPS guidance of $11.20–$11.90 was hardly aspirational, and the accompanying reported EPS guidance of $11.50–$12.20 did little to shift sentiment in a more constructive direction. The Street read the update as confirmation that near-term volume pressure is real and not easily dismissed. Freedom Broker formalized that assessment on July 1, downgrading STZ from Buy to Hold and cutting its price target from $223 to $173, citing consumer financial pressure and beer depletions falling 0.3%.

With the next earnings release not expected until October 5, there is no near-term catalyst capable of resetting the conversation. Until then, weak beer-volume data remains the immediate focus, and today's session made clear that investors are not giving STZ the benefit of the doubt while that data continues to deteriorate.


What is the Constellation Brands, Inc. Rating - Should I Sell?

Weiss Ratings assigns STZ a C- rating. Current recommendation is Hold. That assessment reflects a company caught between pockets of genuine operational strength and a set of risk indicators that are difficult to overlook in the current environment.

On the positive side, the numbers offer some foundation. ROE of 23.69% earns a Good Efficiency Index — a respectable figure for a capital-intensive beverage company managing a large brand portfolio, though its value is somewhat tempered when the top line is contracting. Profit margin of 20.14% similarly supports the Good Efficiency designation, reflecting a business that has historically been able to price its Mexican-import portfolio at a premium and convert revenue into earnings at a reasonable clip. The Excellent Growth Index rounds out the constructive picture, though that rating sits in some tension with the reality of revenue growth of -3.27% — a negative figure that reflects the near-term volume headwinds now working against the company.

Where the C- rating becomes more pointed is in the Weak Total Return Index and Weak Volatility Index. The former signals that cumulative performance for shareholders has been disappointing, a judgment borne out by the stock's 22.9% retreat from its 52-week high. The Weak Volatility Index is a relevant caution for investors with lower risk tolerance: STZ has been prone to sharp, disorderly moves — today's 5.29% single-session decline is a recent example — and the Solvency Index coming in at only Good rather than Excellent is worth monitoring for a company that carries meaningful debt in support of its brand portfolio and ongoing divestitures.

Within the Consumer Staples sector, Constellation Brands ranks below Ambev S.A. (ABEV, C+), Archer-Daniels-Midland Company (ADM, C+), Pepsico, Inc. (PEP, C), Mondelez International, Inc. (MDLZ, C), and Keurig Dr Pepper Inc. (KDP, C). That relative positioning places Constellation among the weaker-rated names in an already cautious sector, reinforcing the Hold stance rather than presenting a clear case for accumulation.


About Constellation Brands, Inc.

Constellation Brands, Inc. (STZ) is a Consumer Staples company built around a portfolio of imported beer, wine, and spirits brands sold primarily in the United States. The company is best known as the exclusive U.S. importer and marketer of the Corona and Modelo families of beers — a licensing relationship with Grupo Modelo that has historically been a powerful source of competitive differentiation, given the premium positioning and strong cultural resonance of Mexican-import beer among U.S. consumers. Constellation also owns a portfolio of wine and spirits brands, though that segment has undergone significant strategic reshaping in recent years as management has pivoted resources toward its higher-margin beer business.

The beer business has been the core of Constellation's growth story over the past decade, with Modelo Especial in particular becoming one of the top-selling beer brands by dollar sales in the U.S. market. The company's go-to-market model combines national distribution infrastructure with targeted marketing, supported by production capacity anchored at its Nava, Mexico brewery. Constellation has invested heavily in expanding that production footprint to meet what was, until recently, reliably growing demand — a capital allocation decision that now carries added scrutiny as volume trends soften.

Beyond beer, Constellation maintains a meaningful wine and spirits presence through brands including Kim Crawford, Robert Mondavi, and High West whiskey, serving retailers, restaurants, and on-premise channels across the country. The company's competitive advantage has long rested on the combination of exclusive import rights, strong brand equity, and disciplined pricing — advantages that remain intact but are being tested by a U.S. consumer increasingly under financial pressure.


Investor Outlook

Constellation Brands, Inc. (STZ) carries a Weiss Rating of C- (Hold), and the near-term path remains clouded by deteriorating beer-volume data and a market that has shown little appetite for absorbing disappointing updates. Investors should watch the October 5 earnings release closely — particularly any revision to full-year EPS guidance and whether Nielsen volume trends show any stabilization in the weeks leading up to it. See full rankings of all C--rated Consumer Staples stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $225.01
B
AAPL NASDAQ $305.59
B
AVGO NASDAQ $392.43
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $114.33
Top Financial Stocks
See All »
B
B
JPM NYSE $360.96
B
V NYSE $358.84
Top Health Care Stocks
See All »
B
LLY NYSE $1,183.16
B
JNJ NYSE $262.37
B
ABBV NYSE $250.33
Top Real Estate Stocks
See All »
B
PLD NYSE $140.62
B
EQIX NASDAQ $1,097.61